BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6246790)

  • 1. PGE1 but not PGI2 desensitizes the PGI2 receptor-adenylate cyclase complex in human foreskin fibroblasts.
    Gorman RR; Hopkins NK
    Adv Prostaglandin Thromboxane Res; 1980; 8():1717-21. PubMed ID: 6246790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-specific desensitization of PGI2-stimulated cyclic AMP accumulation by PGE1 in human foreskin fibroblasts.
    Gorman RR; Hopkins NK
    Prostaglandins; 1980 Jan; 19(1):2-16. PubMed ID: 6247745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
    Crutchley DJ; Conanan LB; Maynard JR
    J Pharmacol Exp Ther; 1982 Sep; 222(3):544-9. PubMed ID: 7050342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandins and inflammation: receptor/cyclase coupling as an explanation of why PGEs and PGI2 inhibit functions of inflammatory cells.
    Weissmann G; Smolen JE; Korchak H
    Adv Prostaglandin Thromboxane Res; 1980; 8():1637-53. PubMed ID: 6246786
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin: a potent activator of human colonic adenylate cyclase activity.
    Simon B; Kather H; Kommerell B
    Z Gastroenterol; 1978 Dec; 16(12):748-51. PubMed ID: 369163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NaCl concentration on adenylate cyclase regulation by prostaglandins and guanine nucleotides.
    Howlett AC
    J Cyclic Nucleotide Res; 1982; 8(2):91-102. PubMed ID: 6757290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of adenylate cyclase to parathyroid hormone and prostaglandins by human isolated glomeruli.
    Ardaillou N; Nivez MP; Schambelan M; Ardaillou R
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1207-15. PubMed ID: 6355140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostaglandins on the adenylate cyclase activity of lungs from fetal rabbits.
    Powell WS; Solomon S
    Endocrinology; 1980 Nov; 107(5):1469-73. PubMed ID: 7000495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human colonic mucosal adenylate cyclase by prostaglandins.
    Simon B; Kather H; Kommerell B
    Adv Prostaglandin Thromboxane Res; 1980; 8():1617-20. PubMed ID: 6246785
    [No Abstract]   [Full Text] [Related]  

  • 16. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
    Sharif NA; Crider JY; Xu SX; Williams GW
    J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGI2 receptors in vasculature and platelets: 5Z-carbacyclin discriminates between them.
    Nicosia S; Oliva D; Noè MA; Corsini A; Folco GC; Fumagalli R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():474-8. PubMed ID: 2959100
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
    McGiff JC; Spokas EG; Wong PY
    Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of prostaglandin E1 binding and activation of adenylate cyclase in normal, malignant and hybrid mammalian cells.
    Ayad SR; Burns GR
    Exp Cell Res; 1977 Aug; 108(1):7-14. PubMed ID: 891636
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interaction of prostaglandin E2 with receptors and their effect on adenylate cyclase activity in human thyroid tissue].
    Gal'chinskaia VIu; Rom-Bugoslavskaia ES; Lille IuE
    Biull Eksp Biol Med; 1986 Mar; 101(3):306-9. PubMed ID: 2869798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.